Buy Azilsartan and Chlorthalidone

Azilsartan and Chlorthalidone

What is Azilsartan and Chlorthalidone?

Azilsartan and Chlorthalidone is a fixed-dose combination pill that contains Azilsartan Medoxomil and Chlorthalidone as its active components. It belongs to the Heart & Blood Pressure therapeutic class and is prescribed to lower elevated blood pressure. The medication is available in a 40 mg/12.5 mg strength, presented as an oral tablet. In the United Kingdom it is a prescription-only medicine (POM) regulated by the MHRA. No specific manufacturer information is provided here; patients should follow the label supplied with their prescription.

How Azilsartan and Chlorthalidone Works in the Body

• Azilsartan Medoxomil is an angiotensin II receptor blocker (ARB). It selectively blocks the AT₁ receptors that mediate vasoconstriction, aldosterone secretion, and sympathetic activation. By preventing angiotensin II from binding, azilsartan promotes vasodilation, reduces sodium-water retention, and lowers peripheral resistance.
• Chlorthalidone is a thiazide-like diuretic. It acts on the distal convoluted tubule of the kidney, inhibiting sodium-chloride reabsorption. This leads to increased urinary excretion of sodium, chloride, and water, decreasing plasma volume and contributing to a reduction in blood pressure.
• The combination provides a dual mechanism: the ARB component controls vascular tone while the diuretic component reduces fluid overload, producing a complementary antihypertensive effect that often allows a single daily pill to achieve target blood pressure.

Conditions Treated by Azilsartan and Chlorthalidone

• Primary hypertension (essential high blood pressure) that requires more than one agent for adequate control.
• The medication is indicated for adult patients when monotherapy with either component alone does not achieve desired blood-pressure goals.

In the UK, the product is approved for use in adults with hypertension; it is not indicated for heart failure, chronic kidney disease, or secondary causes of hypertension unless a specialist determines it appropriate.

Patient Suitability and Contraindications

Who Should Use Azilsartan and Chlorthalidone?

• Adults (≥ 18 years) with diagnosed hypertension whose blood pressure is not controlled by a single antihypertensive agent.
• Patients who can tolerate both an ARB and a thiazide-like diuretic, and who have no contraindications listed below.

Absolute Contraindications

• Known hypersensitivity to azilsartan, chlorthalidone, or any component of the tablet.
• Pregnancy (the drug may impair fetal renal development and cause oligohydramnios).
• Severe renal impairment (eGFR < 30 mL/min/1.73 m²) or anuria.
• Severe hepatic impairment (Child-Pugh C) due to limited data on safety.
• Concomitant use with another potassium-sparing ARB, ACE inhibitor, or direct renin inhibitor (risk of hyperkalemia and renal failure).

Relative Contraindications / Precautions

• Mild to moderate renal impairment - monitor serum creatinine and electrolytes.
• Hepatic disease - dose adjustment may be required.
• Older adults (≥ 65 years) - increased susceptibility to orthostatic hypotension and electrolyte disturbances.
• History of gout - chlorthalidone can raise serum uric acid.
• Electrolyte abnormalities (hypokalemia, hyperkalemia) - regular monitoring is advised.

Patients with any of these conditions should discuss risks and benefits with a healthcare professional before starting therapy.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Dizziness or light-headedness (especially after the first dose).
• Headache.
• Fatigue.
• Increased urination (diuretic effect).
• Electrolyte changes - mild hypokalemia or hyperkalemia (depending on individual response).
• Transient increase in serum creatinine (typically stabilises within 1-2 weeks).

These reactions are generally mild and improve with continued therapy or simple measures such as standing up slowly.

Serious Adverse Events

• Severe hypotension (symptoms: fainting, severe dizziness, shock).
• Hyperkalemia - can lead to cardiac arrhythmia; watch for muscle weakness, palpitations.
• Acute renal failure - especially in patients with bilateral renal artery stenosis or volume depletion.
• Angio-oedema - rare but may present with facial swelling, tongue enlargement, or airway compromise. Immediate medical attention is required.

If any of these occur, stop the medication and seek urgent medical care.

Drug Interactions

• Potassium-containing supplements or salt substitutes - increase risk of hyperkalaemia when combined with azilsartan.
• Lithium - thiazide-like diuretics reduce lithium clearance, raising lithium levels and toxicity risk.
• Non-steroidal anti-inflammatory drugs (NSAIDs) - may blunt antihypertensive effect and worsen renal function.
• Other antihypertensives (beta-blockers, calcium-channel blockers) - additive blood-pressure lowering; monitor for hypotension.
• Digoxin - chlorthalidone may increase digoxin concentrations, requiring dose review.
• Drugs affecting CYP450 enzymes - azilsartan is minimally metabolised but strong CYP3A4 inhibitors could modestly raise plasma levels; monitor clinical response.

Food and Lifestyle Interactions

• The tablet can be taken with or without food; food does not significantly affect absorption.
• Alcohol may potentiate dizziness and hypotension; limit intake, especially when first starting therapy.
• No specific dietary restrictions, but patients should maintain adequate fluid intake to avoid excessive dehydration, which can amplify diuretic-related electrolyte shifts.
• Caution when operating machinery or driving until the individual knows how the medication affects them.

How to Take Azilsartan and Chlorthalidone

• Standard dosing: One tablet (40 mg/12.5 mg) taken once daily, preferably in the morning to align with the diuretic’s natriuretic effect.
• Dose adjustments: A healthcare provider may increase to a higher strength (if available) based on blood-pressure response and tolerability.
• Renal or hepatic impairment: Initiate at the standard dose but monitor renal function and electrolytes closely; dose reduction may be warranted.
• Elderly patients: Start at the usual dose but assess for orthostatic symptoms; consider a slower titration schedule.

Administration tips

• Swallow the tablet whole with a glass of water; do not crush or chew.
• If a dose is missed, take it as soon as remembered once; if it is near the time of the next scheduled dose, skip the missed one-do not double-dose.

Overdose

• Symptoms may include severe hypotension, excessive drowsiness, electrolyte imbalance, or renal dysfunction.
• Seek emergency medical care; treatment is primarily supportive, with intravenous fluids and electrolyte correction as needed.

Discontinuation

• The medication can be stopped abruptly, but patients with well-controlled hypertension should discuss a tapering plan with their clinician to avoid rebound elevation of blood pressure.

Monitoring and Follow-Up

• Blood pressure: Check at each clinic visit until the target (≤ 130/80 mmHg for most adults) is achieved, then at regular intervals (e.g., every 3-6 months).
• Renal function: Serum creatinine and eGFR should be measured before initiation, after 1-2 weeks, and periodically thereafter.
• Electrolytes: Sodium, potassium, and chloride levels are important, especially in the first month of therapy.
• Uric acid: Consider in patients with a history of gout or hyperuricaemia.

Patients should be instructed to contact their healthcare provider if they experience persistent dizziness, swelling, rapid weight gain, or any signs of electrolyte imbalance.

Storage and Handling

• Store the tablets at room temperature (≤ 30 °C), away from excess heat, moisture, and direct sunlight.
• Keep the container tightly closed and out of reach of children.
• Do not use after the expiry date printed on the packaging.
• For safe disposal, follow local NHS guidelines for medication waste (e.g., return to a pharmacy).

Medication-Specific Glossary

Angiotensin II Receptor Blocker (ARB)

A drug class that blocks the AT₁ receptor, preventing vasoconstriction and aldosterone release, thereby lowering blood pressure.

Thiazide-like Diuretic

A diuretic that acts on the distal tubule to promote sodium and water excretion; chlorthalidone is more potent and longer-acting than conventional thiazides.

Hyperkalaemia

An elevated serum potassium level (> 5.0 mmol/L) that can cause cardiac arrhythmias; a recognized risk when ARBs are combined with potassium-sparing agents.

Renal Clearance

The volume of plasma cleared of a substance by the kidneys per unit time; important for dosing adjustments in renal impairment.

Electrolyte Balance

The equilibrium of ions such as sodium, potassium, and chloride in the body; disturbed by diuretics and certain antihypertensives.

Medical Disclaimer

This article provides educational information about Azilsartan and Chlorthalidone and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.